logo
15:44 Dec 05

Kopran Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
135.42
-4.37 (-3.13%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Kopran Ltd. Financials

Kopran Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
135.42
-4.37 (-3.13%)
15:44 Dec 05
Quality
image/svg+xml

46/100
Medium Financial Strength

Valuation
image/svg+xml

45/100
Mid Valuation

Technical

35/100
Technically Bearish

Strength

3

Weakness

11

Opportunity

0

Threats

0

7.43 %

ROE %

4.56 %

ROA %

3.64

EPS

107.35

BVPS

6.12 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
477.52 550.99 614.59 629.6 630.86
Operating Expenses +
390.13 499.2 540.18 556.71 559.59
Raw Material
300.56 345.95 400.88 410.66 399.36
Increase Decrease in Cost
-29.19 12.62 1.06 -6.04 4.77
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
43.27 49.95 52.28 60.54 62.62
Miscellaneous Expenses
81.95 139.36 98.02 110.87 92.84
Operating Profit
87.39 51.79 74.41 72.89 71.27
Other Income
10.6 3.06 14.61 3.98 1.5
Depreciation
11.1 12.71 12.89 15.59 15.98
Interest
5.12 6.08 8.59 9.34 9.7
Profit before tax and exceptio..
81.78 36.07 67.54 51.95 47.09
Exceptional Items
0 0 0 0 0
PBT
81.78 36.07 67.54 51.95 47.09
Provision for Taxation
20.75 8.83 16.59 13.4 12.19
Net Profit
61.03 27.23 50.96 38.55 34.91
NET Profit after MI
61.03 27.23 50.96 38.55 34.91
EPS
13.77 5.65 10.57 7.99 7.71
Operating Profit Margin (%)
18.3 9.4 12.11 11.58 11.3
Net Profit Margin (%)
12.78 4.94 8.29 6.12 5.53

Kopran Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 44.40 44.40 44.40 44.50 44.50 44.50
FII 0.60 0.80 1.10 0.90 1.30 0.70
Public 0.00 0.00 0.00 0.00 0.20 0.10
Others 55.00 54.80 54.50 54.60 54.00 54.70
Shareholder Shares Holding %
Research 360 logo
Download Our App On: